Francesca Fenizia

Naples, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 30 publications

BLOODPAC's collaborations with European Union liquid biopsy initiatives.

BLOODPAC's collaborations with European Union liquid biopsy initiatives.

Journal: The journal of liquid biopsy
Published: July 22, 2025

Indirect clinical validation for predictive biomarkers in oncology: International Quality Network for Pathology (IQN Path) Position Paper.

Indirect clinical validation for predictive biomarkers in oncology: International Quality Network for Pathology (IQN Path) Position Paper.

Journal: Virchows Archiv : an international journal of pathology
Published: May 23, 2025

Results of a worldwide external quality assessment of cfDNA testing in lung Cancer.

Results of a worldwide external quality assessment of cfDNA testing in lung Cancer.

Journal: BMC cancer
Published: March 16, 2022

Validation of a Targeted Next-Generation Sequencing Panel for Tumor Mutation Burden Analysis: Results from the Onconetwork Immuno-Oncology Consortium.

Validation of a Targeted Next-Generation Sequencing Panel for Tumor Mutation Burden Analysis: Results from the Onconetwork Immuno-Oncology Consortium.

Journal: The Journal of molecular diagnostics : JMD
Published: September 30, 2020

Tumor mutation burden testing: a survey of the International Quality Network for Pathology (IQN Path).

Tumor mutation burden testing: a survey of the International Quality Network for Pathology (IQN Path).

Journal: Virchows Archiv : an international journal of pathology
Published: July 22, 2020

Targeted sequencing analysis of cell-free DNA from metastatic non-small-cell lung cancer patients: clinical and biological implications.

Targeted sequencing analysis of cell-free DNA from metastatic non-small-cell lung cancer patients: clinical and biological implications.

Journal: Translational lung cancer research
Published: March 25, 2020

Challenges in bioinformatics approaches to tumor mutation burden analysis.

Challenges in bioinformatics approaches to tumor mutation burden analysis.

Journal: Oncology letters
Published: March 19, 2020

Biomarker testing in oncology - Requirements for organizing external quality assessment programs to improve the performance of laboratory testing: revision of an expert opinion paper on behalf of IQNPath ABSL.

Biomarker testing in oncology - Requirements for organizing external quality assessment programs to improve the performance of laboratory testing: revision of an expert opinion paper on behalf of IQNPath ABSL.

Journal: Virchows Archiv : an international journal of pathology
Published: June 26, 2019

Genomic Profiling of KRAS/NRAS/BRAF/PIK3CA Wild-Type Metastatic Colorectal Cancer Patients Reveals Novel Mutations in Genes Potentially Associated with Resistance to Anti-EGFR Agents.

Genomic Profiling of KRAS/NRAS/BRAF/PIK3CA Wild-Type Metastatic Colorectal Cancer Patients Reveals Novel Mutations in Genes Potentially Associated with Resistance to Anti-EGFR Agents.

Journal: Cancers
Published: May 15, 2019

The Presence of Concomitant Mutations Affects the Activity of EGFR Tyrosine Kinase Inhibitors in EGFR-Mutant Non-Small Cell Lung Cancer (NSCLC) Patients.

The Presence of Concomitant Mutations Affects the Activity of EGFR Tyrosine Kinase Inhibitors in EGFR-Mutant Non-Small Cell Lung Cancer (NSCLC) Patients.

Journal: Cancers
Published: February 12, 2019

Measuring tumor mutation burden in non-small cell lung cancer: tissue versus liquid biopsy.

Measuring tumor mutation burden in non-small cell lung cancer: tissue versus liquid biopsy.

Journal: Translational lung cancer research
Published: December 04, 2018

The role of circulating free DNA in the management of NSCLC.

The role of circulating free DNA in the management of NSCLC.

Journal: Expert review of anticancer therapy
Published: November 22, 2018
Showing 1-12 of 30

Last Updated: 09/26/2026